Kalyan Singh Super Speciality Cancer Institute and CSIR-Central Drug Research Institute Sign MoU to Strengthen Collaborative Research and Innovation in Cancer & Biomedical Sciences
Kalyan Singh Super Speciality Cancer Institute and CSIR-Central Drug Research Institute Sign MoU to Strengthen Collaborative Research and Innovation in Cancer & Biomedical Sciences

February 18, 2026


Today, Kalyan Singh Super Speciality Cancer Institute (KSSSCI), Lucknow and CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow have signed a collaborative MoU to promote joint research, academic exchange, and innovation in areas of mutual interest, particularly in cancer and biomedical sciences.
Under this collaboration, both institutions will undertake joint research programs, explore traineeship opportunities for students at CSIR-CDRI, facilitate faculty exchange, share advanced instrumentation facilities as per institutional guidelines, and jointly submit research proposals to funding agencies.
This partnership aims to strengthen translational research, capacity building, and improvement of healthcare in the community through the output of the research.
On this occasion, The Director General, CSIR-CDRI, Director, KSSSCI, Prof. M.L.B. Bhatt, Director, CSIR-CDRI, Executive Registrar, Dr. Ayush Lohiya, Medical Superintendent, Dr. Varun Vijay were present and expressed their commitment to fostering impactful collaborative research and academic excellence through this initiative.